$CVS
CVS HEALTH Corp

2016 Q2 Form 10-Q Financial Statement

#000006480316000090 Filed on August 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $43.73B $37.17B
YoY Change 17.64% 7.42%
Cost Of Revenue $36.71B $30.77B
YoY Change 19.32% 8.8%
Gross Profit $7.015B $6.402B
YoY Change 9.58% 1.23%
Gross Profit Margin 16.04% 17.22%
Selling, General & Admin $4.674B $4.140B
YoY Change 12.9% 0.58%
% of Gross Profit 66.63% 64.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.665B $4.140B
YoY Change 12.68% 0.58%
Operating Profit $2.350B $2.262B
YoY Change 3.89% 2.45%
Interest Expense $284.0M $171.0M
YoY Change 66.08% 6.21%
% of Operating Profit 12.09% 7.56%
Other Income/Expense, Net $9.000M
YoY Change
Pretax Income $1.528B $2.096B
YoY Change -27.1% 2.24%
Income Tax $604.0M $824.0M
% Of Pretax Income 39.53% 39.31%
Net Earnings $924.0M $1.272B
YoY Change -27.36% 2.09%
Net Earnings / Revenue 2.11% 3.42%
Basic Earnings Per Share $0.86 $1.13
Diluted Earnings Per Share $0.86 $1.12
COMMON SHARES
Basic Shares Outstanding 1.070B shares 1.124B shares
Diluted Shares Outstanding 1.075B shares 1.132B shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.207B $1.404B
YoY Change -14.03% -17.99%
Cash & Equivalents $1.127B $1.244B
Short-Term Investments $80.00M $160.0M
Other Short-Term Assets $881.0M $732.0M
YoY Change 20.36% 32.13%
Inventory $14.18B $12.38B
Prepaid Expenses
Receivables $13.18B $10.89B
Other Receivables $0.00 $0.00
Total Short-Term Assets $29.45B $26.40B
YoY Change 11.54% 9.38%
LONG-TERM ASSETS
Property, Plant & Equipment $9.981B $9.019B
YoY Change 10.67% 2.26%
Goodwill $38.19B $28.12B
YoY Change 35.8% -0.01%
Intangibles $13.64B $9.683B
YoY Change 40.86% -2.25%
Long-Term Investments
YoY Change
Other Assets $1.490B $1.443B
YoY Change 3.26% -9.98%
Total Long-Term Assets $63.30B $48.27B
YoY Change 31.15% -0.39%
TOTAL ASSETS
Total Short-Term Assets $29.45B $26.40B
Total Long-Term Assets $63.30B $48.27B
Total Assets $92.75B $74.67B
YoY Change 24.21% 2.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.351B $6.370B
YoY Change 15.4% 10.21%
Accrued Expenses $7.244B $5.543B
YoY Change 30.69% 15.19%
Deferred Revenue
YoY Change
Short-Term Debt $745.0M $1.488B
YoY Change -49.93%
Long-Term Debt Due $2.291B $24.00M
YoY Change 9445.83% -97.86%
Total Short-Term Liabilities $26.57B $20.39B
YoY Change 30.33% 22.59%
LONG-TERM LIABILITIES
Long-Term Debt $25.60B $11.63B
YoY Change 120.06% -5.05%
Other Long-Term Liabilities $1.553B $1.490B
YoY Change 4.23% 0.07%
Total Long-Term Liabilities $1.553B $1.490B
YoY Change 4.23% 0.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.57B $20.39B
Total Long-Term Liabilities $1.553B $1.490B
Total Liabilities $28.12B $21.88B
YoY Change 28.55% 20.74%
SHAREHOLDERS EQUITY
Retained Earnings $36.65B $33.54B
YoY Change 9.25% 11.0%
Common Stock $17.00M $17.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $33.01B $26.99B
YoY Change 22.31% 21.95%
Treasury Stock Shares 638.0M shares 578.0M shares
Shareholders Equity $34.76B $37.13B
YoY Change
Total Liabilities & Shareholders Equity $92.75B $74.67B
YoY Change 24.21% 2.86%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $924.0M $1.272B
YoY Change -27.36% 2.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $1.647B $1.037B
YoY Change 58.82% 15.61%
INVESTING ACTIVITIES
Capital Expenditures -$504.0M -$523.0M
YoY Change -3.63% 3.98%
Acquisitions
YoY Change
Other Investing Activities -$94.00M -$23.00M
YoY Change 308.7% -81.15%
Cash From Investing Activities -$598.0M -$546.0M
YoY Change 9.52% -12.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.702B -761.0M
YoY Change 123.65% -46.52%
NET CHANGE
Cash From Operating Activities 1.647B 1.037B
Cash From Investing Activities -598.0M -546.0M
Cash From Financing Activities -1.702B -761.0M
Net Change In Cash -653.0M -270.0M
YoY Change 141.85% -76.54%
FREE CASH FLOW
Cash From Operating Activities $1.647B $1.037B
Capital Expenditures -$504.0M -$523.0M
Free Cash Flow $2.151B $1.560B
YoY Change 37.88% 11.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 cvs Charitable Contributiontothe Cvs Foundation
CharitableContributiontotheCVSFoundation
32000000 USD
CY2015Q4 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
7653000000 USD
CY2016Q2 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
8938000000 USD
CY2016Q2 cvs Debt Instrument Redemption Redemption Premium
DebtInstrumentRedemptionRedemptionPremium
486000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
6000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
75000000 USD
CY2016Q2 cvs Guaranteed Store Leases
GuaranteedStoreLeases
91 store_lease
CY2015Q4 cvs Longtermdebtcurrentmaturitiesincludingcapitalleases
Longtermdebtcurrentmaturitiesincludingcapitalleases
1197000000 USD
CY2016Q2 cvs Longtermdebtcurrentmaturitiesincludingcapitalleases
Longtermdebtcurrentmaturitiesincludingcapitalleases
2291000000 USD
CY2015Q4 cvs Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
26267000000 USD
CY2016Q2 cvs Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
25600000000 USD
CY2015Q3 cvs Loss Contingency Cases Consolidated Number
LossContingencyCasesConsolidatedNumber
2 class_action_complaint
CY2015Q3 cvs Loss Contingency Prescription Drug Plan Supply Duration
LossContingencyPrescriptionDrugPlanSupplyDuration
P90D
CY2010Q1 cvs Number Of States Participating In Multistate Investigations
NumberOfStatesParticipatingInMultistateInvestigations
28 state
cvs Proceedsfrom Saleof Property Plantand Equipmentand Other Assets
ProceedsfromSaleofPropertyPlantandEquipmentandOtherAssets
14000000 USD
cvs Proceedsfrom Saleof Property Plantand Equipmentand Other Assets
ProceedsfromSaleofPropertyPlantandEquipmentandOtherAssets
11000000 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
0 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
39000000 USD
cvs Yearthe Last Lease Expires
YeartheLastLeaseExpires
2047
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000064803
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1066214990 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CVS HEALTH CORPORATION
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7490000000 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7351000000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11888000000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13183000000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6829000000 USD
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7244000000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-358000000 USD
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-317000000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30948000000 USD
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31454000000 USD
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
88000000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
107000000 USD
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5700000 shares
CY2015Q4 us-gaap Assets
Assets
92437000000 USD
CY2016Q2 us-gaap Assets
Assets
92748000000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
29158000000 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
29448000000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2481000000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1244000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2459000000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1127000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1237000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1332000000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.350
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.700
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.425
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.850
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2015Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2016Q2 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2015Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2016Q2 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1699000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1704000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1101000000 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1065000000 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1281000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2455000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
946000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2111000000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1281000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2455000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
946000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2112000000 USD
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
30767000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
60935000000 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
36710000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
73181000000 USD
CY2016Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27900000000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4217000000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4260000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
978000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1236000000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.20
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.91
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.19
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.90
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
97000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
63000000 USD
CY2015Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542000000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
38106000000 USD
CY2016Q2 us-gaap Goodwill
Goodwill
38190000000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
6402000000 USD
us-gaap Gross Profit
GrossProfit
12566000000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
7015000000 USD
us-gaap Gross Profit
GrossProfit
13759000000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2096000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4094000000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1528000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3421000000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1272000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2493000000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
924000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2071000000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
824000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1601000000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
604000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1350000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1627000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1762000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1383000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1164000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1211000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1279000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-241000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
492000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
465000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
167000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-131000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
170000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
48000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
53000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-93000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5000000 USD
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6000000 shares
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13878000000 USD
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13639000000 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
171000000 USD
us-gaap Interest Expense
InterestExpense
309000000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
284000000 USD
us-gaap Interest Expense
InterestExpense
572000000 USD
CY2015Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-166000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-300000000 USD
CY2016Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-280000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-563000000 USD
us-gaap Interest Paid
InterestPaid
311000000 USD
us-gaap Interest Paid
InterestPaid
615000000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
14001000000 USD
CY2016Q2 us-gaap Inventory Net
InventoryNet
14177000000 USD
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
9000000 USD
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
9000000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92437000000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92748000000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23169000000 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26569000000 USD
CY2016Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
30500000000 USD
CY2003Q4 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
3 class_action_complaint
CY2015Q3 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
2 class_action_complaint
CY2003Q4 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
2 defendant
CY2015Q4 us-gaap Minority Interest
MinorityInterest
7000000 USD
CY2016Q2 us-gaap Minority Interest
MinorityInterest
6000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3167000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4126000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1090000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1231000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3021000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4023000000 USD
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1272000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2493000000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
924000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2070000000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1265000000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2481000000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
920000000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2060000000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
4140000000 USD
us-gaap Operating Expenses
OperatingExpenses
8172000000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
4665000000 USD
us-gaap Operating Expenses
OperatingExpenses
9233000000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2262000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4394000000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2350000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4526000000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
722000000 USD
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
881000000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1440000000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1490000000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
40000000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
22000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
41000000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1542000000 USD
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1553000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2934000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3960000000 USD
CY2016Q2 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
6000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
794000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
929000000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
124000000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
39000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
112000000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
36647000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
168000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
942000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1102000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
58129000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
70851000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
7935000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
7082000000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
71014000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
84324000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
9000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
9000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3455000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
803000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
745000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
40000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
67000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
211000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
122000000 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
1272000000 USD
us-gaap Profit Loss
ProfitLoss
2493000000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
924000000 USD
us-gaap Profit Loss
ProfitLoss
2071000000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9855000000 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9981000000 USD
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
39000000 USD
CY2016Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 USD
CY2015Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
3000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
7000000 USD
CY2016Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
22000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
550000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3579000000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35506000000 USD
CY2015Q2 us-gaap Revenues
Revenues
37169000000 USD
us-gaap Revenues
Revenues
73501000000 USD
CY2016Q2 us-gaap Revenues
Revenues
43725000000 USD
us-gaap Revenues
Revenues
86940000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
34000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
88000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
107000000 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4000000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.03
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
25000000 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.62
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
104.82
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M17D
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2016Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
745000000 USD
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
88000000 USD
CY2016Q2 us-gaap Short Term Investments
ShortTermInvestments
80000000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
37196000000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
34760000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37203000000 USD
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34766000000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
597000000 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
638000000 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
28886000000 USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
33010000000 USD
CY2015Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
7000000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
12000000 USD
CY2016Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
4000000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10000000 USD
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1132000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1134000000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1075000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1087000000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1124000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1126000000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1070000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1081000000 shares
CY2016Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
50000000 USD

Files In Submission

Name View Source Status
0000064803-16-000090-index-headers.html Edgar Link pending
0000064803-16-000090-index.html Edgar Link pending
0000064803-16-000090.txt Edgar Link pending
0000064803-16-000090-xbrl.zip Edgar Link pending
a1282016cvslogoa01.gif Edgar Link pending
cvs-20160630.xml Edgar Link completed
cvs-20160630.xsd Edgar Link pending
cvs-20160630_cal.xml Edgar Link unprocessable
cvs-20160630_def.xml Edgar Link unprocessable
cvs-20160630_lab.xml Edgar Link unprocessable
cvs-20160630_pre.xml Edgar Link unprocessable
cvs20160630-10q.htm Edgar Link pending
cvs20160630ex311.htm Edgar Link pending
cvs20160630ex312.htm Edgar Link pending
cvs20160630ex321.htm Edgar Link pending
cvs20160630ex322.htm Edgar Link pending
exhibit151q216eyconsent.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending